Nathaniel S. Gardiner - 18 Apr 2023 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Role
Sr. VP & General Counsel
Signature
/s/ Nathaniel S. Gardiner
Issuer symbol
ENTA
Transactions as of
18 Apr 2023
Net transactions value
+$200,010
Form type
4
Filing time
19 Apr 2023, 19:25:26 UTC
Previous filing
15 Feb 2023
Next filing
22 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENTA Common Stock Options Exercise $200,010 +6,667 +9.1% $30.00 79,980 18 Apr 2023 Direct
holding ENTA Common Stock 28,107 18 Apr 2023 By grantor retained annuity trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENTA Stock Option (Right to Buy) Options Exercise $0 -6,667 -49% $0.000000 7,000 18 Apr 2023 Common Stock 6,667 $30.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by a grantor retained annuity trust created by the reporting person for the benefit of himself and his two adult children.
F2 100% of the shares subject to the option are fully vested and exercisable.